Gold prices fall as geopolitical tensions ease; U.S. CPI looms
Radiopharm Theranostics Ltd (NASDAQ:RAD) announced Tuesday the appointment of Dr. Oliver Sartor to its Scientific Advisory Board. The company disclosed the appointment in a press release statement furnished to the U.S. Securities and Exchange Commission.
According to the filing, Radiopharm Theranostics made the announcement to the Australian Securities Exchange earlier Tuesday. Dr. Sartor’s addition to the Scientific Advisory Board was the sole topic addressed in the public notice referenced in the SEC filing.
No further details regarding Dr. Sartor’s role or background were provided in the filing.
Radiopharm Theranostics Ltd is a pharmaceutical company focused on the development of radiopharmaceutical products. The information in this article is based on a press release statement filed with the SEC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.